A new study published on 8 January in Advanced Materials has presented a novel biomaterial with the unique ability to enable cell-selective activation of growth factors ― signalling proteins that
All posts in Public Health
Computer vision and artificial intelligence are helping doctors diagnose rare disorders
A recent study published on 7 January in Nature Medicine has shown that a smartphone app called Face2Gene designed to help diagnose a range of rare genetic disorders by analysing
According to a paper published on 2 January in Science Translational Medicine, ‘nanoscavengers’ or ‘bioscavengers’ may offer an effective treatment against the highly toxic nerve agents used in chemical attacks
Dramatic reductions in particulate air pollution in China may have unexpectedly increased ozone pollution
Since 2013, the Chinese government has been enforcing strict policies on emissions in an effort to reduce fine particulate air pollution, known as PM 2.5, a major problem in Chinese
A study published on 19 December in Nature Communications has shown that the active ingredient in eyedrops originally being developed to treat eye disease may be effective in treating an
This week, the PsychENCODE Consortium published a collection of 10 research papers in Science, Science Advances, and Science Translational Medicine presenting 3 years of work aimed at understanding the complex
A report presented on 8 December at a side event to the UN Intergovernmental Conference to adopt the Global Compact for Safe, Orderly and Regular Migration in Marrakech, Morrocco has
At a scientific conference on 26 November, a researcher from the Southern University of Science and Technology in Shenzhen, China made the shocking announcement that he has created the world’s
Reshuffling of DNA in neurons may be linked to Alzheimer’s disease, landmark study finds
Scientists have known for a long time that certain cells have the ability to shuffle their DNA around ― called somatic recombination ― and now a “landmark study” published on
European Medicines Agency recommends ‘rediscovered drug’ for treating sleeping sickness in Africa
On 16 November the European Medicines Agency (EMA) approved a new drug, fexinidazole, for treating human African trypanosomiasis, known as sleeping sickness. The neglected tropical disease is endemic to Africa
 
			 
			 
			 
			 
			 
			 
			 
			 
			